相关实验视频
Updated: Sep 10, 2025

06:17
Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
24.3K
骨质细胞基因突变是骨质细胞相关疾病的原因
Jelena M Živković1, Jelena G Najdanović1, Stevo J Najman1,2
1Department of Biology and Human Genetics, Faculty of Medicine, University of Niš, Niš, Serbia.
DNA and cell biology
|August 25, 2025
概括
骨质细胞基因突变导致罕见的骨疾病,导致骨再吸收发生改变. 了解这些细胞和分子机制是开发针对骨质细胞相关疾病的基因治疗的关键.
科学领域:
- 细胞生物学
- 遗传学
- 骨生物学
背景情况:
- 骨质细胞对于骨重塑,包括发育,维护,修复和再生至关重要.
- 由于遗传突变,功能障碍的骨质细胞导致罕见的骨疾病,其特征是异常的骨再吸收.
- 这些疾病不仅影响骨系统,也影响整个生物体.
研究的目的:
- 阐明骨质细胞发育和功能的细胞和分子机制.
- 了解骨质细胞基因突变对骨质细胞相关疾病的影响.
- 确定特定的基因突变作为个性化基因治疗的潜在治疗点.
主要方法:
- 对骨质细胞生物学和遗传性骨病的现有文献进行审查.
- 控制骨质细胞分化和功能的细胞和分子通路的分析.
- 鉴定与骨质细胞相关疾病相关的基因.
主要成果:
- 骨质细胞功能障碍是由控制其分化和功能的基因突变引起的.
- 与骨质细胞相关的疾病表现为骨质再吸收减少或增加.
- 特定的基因突变与这些罕见的骨疾病的发病有关.
结论:
- 了解骨质细胞生物学对于了解骨质细胞相关疾病至关重要.
- 针对特定的基因突变为开发个性化基因疗法提供了有前途的途径.
- 对骨质细胞基因功能的进一步研究可以促进骨疾病的治疗.
相关概念视频
Osteoclasts in Bone Remodeling
3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K
Mutations
84.2K
Overview
84.2K
Translation
15.5K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
15.5K
Bone Disorders
3.9K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.9K
Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K

